Rigel Pharmaceuticals | Der Umsatz

Aktienkurs
33.50
Täglich Wechseln
-1.12 -3.24%
Monatlich
-16.17%
Jährlich
60.75%
Q1 Prognose
1.20




Der Umsatz Veränderung Datum
Agenus USD 24.07M 2.77M 2025-03
Amgen USD 9.9B 340M 2025-12
Anika Therapeutics USD 26.17M 12.58M 2025-03
Arrowhead Research USD 264.03M 7.56M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celldex Therapeutics USD 890K 160K 2025-09
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Halozyme Therapeutics USD 354M 148M 2025-09
Heron Therapeutics USD 32.81M 3.21M 2024-09
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 157M 295M 2025-09
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Ligand Pharmaceuticals USD 115.46M 67.83M 2025-09
MacroGenics USD 72.84M 50.6M 2025-09
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
Veracyte USD 131.9M 1.74M 2025-09


Rigel Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.